Drug recall · April 15, 2015
Fexofenadine HCl Tablets recall
Why: Failed Impurities/Degradation Specifications: out of specification results for a related compound - a degradant of fexofenadine.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Fexofenadine HCl Tablets, USP, 60 mg, Allergy, Antihistamine, Indoor and Outdoor Allergies, Non-Drowsy, Original Prescription Strength, a) 60 count Bottles, NDC 0378-0781-91, b) 500 count Bottles, NDC 0378-0781-05, Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, USA.
- Lots / codes
Lot #: 3047303, Exp 04/2015
- Quantity
- 13,856 Bottles
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Nationwide
- Initiated
- March 11, 2015 · Voluntary: Firm initiated
- Classified
- April 7, 2015
- Reported
- April 15, 2015
- Ended
- October 9, 2015
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fexofenadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.